Clinical Trial Update: Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study) [NA]

View source ↗

Summary

A recruiting clinical trial evaluating the efficacy of pHA130 hemoadsorption for 4 hours in patients with end-stage renal disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• pHA130 Hemoadsorption

Snippet

Sponsor: Peking University People's Hospital | Conditions: End Stage Renal Disease on Dialysis | NA | Status: RECRUITING